Christopher P Mill

12PUBLICATIONS
25CO-AUTHORS
Molecular medicineMedical molecular engineering of nucleic acids and proteinsMechatronics hardware design and architectureRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 12, 2026
Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.

Christine E Birdwell, Warren Fiskus, Christopher P Mill

|Feb 24, 2026
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Warren Fiskus, Christopher P Mill, Ghayas C Issa

|Dec 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.

Christine E Birdwell, Warren Fiskus, Christopher P Mill

|Aug 19, 2025
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase.

Warren Fiskus, Lucia Masarova, Christopher P Mill

|May 21, 2025
Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.

Warren Fiskus, Christopher P Mill, Christine Birdwell

|Mar 16, 2025
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations.

Warren Fiskus, Christopher P Mill, Jessica Piel

Pageof 2

Frequent Collaborators

12 joint publications

Warren Fiskus

12 joint publications

Courtney DiNardo

9 joint publications

Naval G Daver

9 joint publications

Sanam Loghavi